搜索





搜索





市场行情
/
股票
/
rlmd
/

Relmada Therapeutics Inc

RLMD

添加自选

5.310USD

0.0000.00%

收盘 07-31 16:00（美东）报价延迟15分钟

556.97M总市值

亏损市盈率 TTM

Relmada Therapeutics Inc

5.310

0.0000.00%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

RLMD 利润表

您可以在这里找到Relmada Therapeutics Inc的年度或季度收入报告，以深入了解Relmada Therapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q4

FY2014Q1

FY2013Q4

FY2013Q3

FY2013Q2

FY2013Q1

FY2012Q4

FY2012Q3

FY2012Q2

FY2012Q1

营业总收入

----

--0.00

-100.00%0.00

58.50%634.00

-61.07%2.35K

--2.15K

--1.51K

--400.00

--6.03K

--0.00

营业收入

----

--0.00

-100.00%0.00

58.50%634.00

-61.07%2.35K

--2.15K

--1.51K

--400.00

--6.03K

--0.00

主营业务成本

----

-100.00%0.00

10.27%322.00

-58.66%1.86K

--1.85K

--998.00

--292.00

--4.51K

--0.00

营业费用

6.82%19.46M

6.59%20.33M

-55.12%10.33M

-45.69%10.22M

-20.75%18.22M

-28.90%19.08M

1.39%23.01M

-27.69%18.82M

-18.35%22.99M

-30.68%26.83M

-41.42%22.69M

-42.81%26.03M

-26.49%28.15M

13.22%38.70M

-9.18%38.74M

71.99%45.51M

70.93%38.30M

63.37%34.18M

148.22%42.65M

107.43%26.46M

124.63%22.41M

405.92%20.92M

535.96%17.18M

266.69%12.76M

313.67%9.97M

114.27%4.14M

5.96%2.70M

138.85%3.48M

145.83%2.41M

8.26%1.93M

11.69%2.55M

-5.19%1.46M

-39.33%980.86K

-42.53%1.78M

-16.90%2.28M

-73.15%1.54M

-65.08%1.62M

-29.87%3.10M

-39.86%2.75M

30.50%5.72M

24.37%4.63M

-63.84%4.42M

--4.57M

--4.38M

422.91%3.72M

98856.02%12.23M

6273.86%711.90K

21.88%12.36K

598.33%20.12K

5.53%6.49K

2444.19%11.17K

--10.14K

--2.88K

--6.15K

--439.00

研发费用

-32.33%8.09M

-26.61%8.07M

-63.80%4.04M

-73.70%2.82M

-10.18%11.95M

-25.43%11.00M

6.65%11.15M

-21.97%10.72M

-16.11%13.31M

-45.10%14.75M

-65.76%10.45M

-55.55%13.74M

-36.59%15.86M

6.31%26.87M

-10.19%30.53M

78.36%30.91M

78.38%25.01M

69.58%25.27M

202.51%33.99M

225.54%17.33M

211.07%14.02M

385.48%14.90M

780.69%11.24M

323.40%5.32M

217.12%4.51M

220.03%3.07M

-23.45%1.28M

734.27%1.26M

757.61%1.42M

419.78%959.25K

239.71%1.67M

-40.69%150.72K

-54.48%165.75K

-69.93%184.55K

-19.44%490.69K

-88.00%254.11K

-87.29%364.15K

-78.58%613.75K

-73.22%609.12K

1.27%2.12M

298.57%2.87M

358.97%2.86M

--2.27M

--2.09M

233.18%718.97K

--624.17K

--215.79K

----

折旧摊销及损耗

----

--0.00

-100.00%0.00

-56.07%452.00

-22.94%806.00

-24.36%823.00

-20.56%854.00

-20.97%1.03K

-25.55%1.05K

17.12%1.09K

89.26%1.07K

123.71%1.30K

156.39%1.41K

-94.91%929.00

-97.56%568.00

-97.53%582.00

-97.28%548.00

-14.44%18.26K

-15.60%23.27K

698.00%23.58K

582.80%20.16K

545.33%21.34K

1026.23%27.57K

--2.96K

-17.84%2.95K

45.04%3.31K

--2.45K

----

7088.00%3.59K

1420.00%2.28K

--50.00

--150.00

--100.00

----

营业利润

-6.82%-19.46M

-6.59%-20.33M

55.12%-10.33M

45.69%-10.22M

20.75%-18.22M

28.90%-19.08M

-1.39%-23.01M

27.69%-18.82M

18.35%-22.99M

30.68%-26.83M

41.42%-22.69M

42.81%-26.03M

26.49%-28.15M

-13.22%-38.70M

9.18%-38.74M

-71.99%-45.51M

-70.93%-38.30M

-63.37%-34.18M

-148.22%-42.65M

-107.43%-26.46M

-124.63%-22.41M

-405.92%-20.92M

-535.96%-17.18M

-266.69%-12.76M

-313.67%-9.97M

-114.27%-4.14M

-5.96%-2.70M

-138.85%-3.48M

-145.83%-2.41M

-8.26%-1.93M

-11.69%-2.55M

5.19%-1.46M

39.33%-980.86K

42.53%-1.78M

16.90%-2.28M

73.15%-1.54M

65.08%-1.62M

29.87%-3.10M

39.86%-2.75M

-30.50%-5.72M

-24.37%-4.63M

63.84%-4.42M

---4.57M

---4.38M

-422.91%-3.72M

-98856.02%-12.23M

-7792.42%-711.90K

-43.28%-12.36K

-685.37%-19.48K

-3190.48%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---126.00

---439.00

净非营业利息收入（费用）

利息收入

117.99%959.76K

-40.85%387.23K

-71.16%247.01K

-66.62%321.46K

-58.30%440.29K

-48.01%654.64K

-35.19%856.48K

-29.37%963.01K

-12.57%1.06M

12.98%1.26M

59.67%1.32M

252.00%1.36M

266.01%1.21M

602.52%1.11M

178.05%827.61K

19.99%387.33K

-21.44%329.95K

--158.65K

--297.65K

--322.81K

--419.97K

----

-83.49%843.00

-50.68%1.04K

-12.62%1.23K

--2.43K

--5.11K

--2.12K

--1.41K

--0.00

----

利息费用

----

6.74%1.17K

-49.76%1.64K

-99.86%431.00

--125.00

--1.10K

-97.36%3.27K

--311.81K

--123.80K

----

出售证券收益

-115.67%-9.87K

-364.23%-107.92K

-155.09%-81.44K

-64.54%47.20K

24.13%62.95K

101.22%40.84K

385.87%147.84K

--133.11K

107.61%50.71K

-9932.59%-3.35M

90.79%-51.71K

-100.00%0.00

-4338.21%-666.71K

72.82%-33.35K

-66.69%-561.65K

119.83%24.50K

71.54%-15.02K

-238.22%-122.68K

-291.02%-336.95K

-1064.79%-123.59K

69.24%-52.79K

--88.76K

---86.17K

--12.81K

---171.61K

----

特殊收入（费用）

-446.81%-540.10K

167.15%186.04K

-74.77%70.28K

69.65%-13.80K

193.10%155.73K

-107.39%-277.07K

148.10%278.56K

92.89%-45.47K

-95.88%53.13K

1260.84%3.75M

38.88%-579.15K

46.08%-639.63K

173.22%1.29M

-39.47%-323.12K

-1192.30%-947.51K

-310.10%-1.19M

-895.29%-1.76M

-52.72%-231.68K

2098.30%86.75K

-123.67%-289.28K

81.05%-177.16K

---151.71K

--3.95K

134.81%1.22M

-193.50%-934.92K

100.00%0.00

-1129.17%-3.51M

-5486.48%-318.54K

-484.77%-789.44K

-204.42%-254.86K

-24.04%341.11K

92.88%-5.70K

173.69%205.17K

-70.66%244.07K

-86.23%449.04K

-100.86%-80.04K

-102.66%-278.42K

-60.43%831.97K

-66.84%3.26M

135.59%9.29M

168.47%10.47M

--2.10M

--9.84M

-456.29%-26.11M

---15.28M

--7.33M

--0.00

100.00%0.00

--0.00

---377.00

--0.00

-固定资产出售收益

----

100.00%0.00

----

---96.40K

----

其他非经营性收入（费用）

----

--0.00

----

-100.00%0.00

----

--0.00

--6.35M

----

--0.00

-100.00%0.00

-95.87%2.35K

-34.60%40.29K

4.31%56.91K

--56.91K

--61.61K

--54.56K

----

税前利润

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

所得税

----

--4.42K

----

--0.00

----

--0.00

----

--0.00

除税后利润

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

持续经营利润

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

反常净利润

----

--0.00

----

归属于母公司的净利润

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

归属于普通股东的净利润

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

基本每股收益

61.90%-0.22

47.41%-0.33

57.77%-0.30

49.52%-0.30

20.29%-0.58

26.05%-0.62

1.50%-0.72

29.95%-0.59

17.16%-0.72

33.67%-0.84

44.25%-0.73

36.98%-0.84

37.53%-0.87

29.99%-1.26

46.21%-1.31

14.31%-1.33

-4.43%-1.40

-41.03%-1.80

-131.39%-2.44

-114.56%-1.56

-85.10%-1.34

-155.28%-1.28

-194.53%-1.05

34.90%-0.73

32.78%-0.72

53.15%-0.50

64.96%-0.36

-144.95%-1.11

-243.84%-1.08

-99.13%-1.07

-55.00%-1.02

-32.82%-0.46

42.54%-0.31

51.43%-0.54

-6.26%-0.66

60.25%-0.34

-131.58%-0.55

-149.10%-1.10

32.45%-0.62

-140.09%-0.86

111.78%1.73

104.98%2.25

---0.92

--2.15

-662.23%-14.65

-490478.26%-45.13

34392.11%2.61

13.21%-0.01

-361.11%-0.02

-350.00%0.00

-1166.67%-0.01

---0.01

--0.00

稀释每股收益

61.90%-0.22

47.41%-0.33

57.77%-0.30

49.52%-0.30

20.29%-0.58

26.05%-0.62

1.50%-0.72

29.95%-0.59

17.16%-0.72

33.67%-0.84

44.25%-0.73

36.98%-0.84

37.53%-0.87

29.99%-1.26

46.21%-1.31

14.31%-1.33

-4.43%-1.40

-41.03%-1.80

-131.39%-2.44

-114.56%-1.56

-85.10%-1.34

-155.28%-1.28

-194.53%-1.05

34.90%-0.73

32.78%-0.72

53.15%-0.50

64.96%-0.36

-144.95%-1.11

-243.84%-1.08

-99.13%-1.07

-55.00%-1.02

-32.82%-0.46

42.54%-0.31

51.43%-0.54

-6.26%-0.66

60.25%-0.34

-137.82%-0.55

-149.10%-1.10

32.45%-0.62

-155.64%-0.86

109.84%1.44

104.98%2.25

---0.92

--1.55

-662.23%-14.65

-490478.26%-45.13

34392.11%2.61

13.21%-0.01

-361.11%-0.02

-350.00%0.00

-1166.67%-0.01

---0.01

--0.00

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Relmada Therapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 RLMD 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Relmada Therapeutics Inc 全年的净利润是多少？



Relmada Therapeutics Inc 2025 财年净利润为 -57.39M。

Relmada Therapeutics Inc 上一季度的净利润是多少？



Relmada Therapeutics Inc 最近一个季度的净利润为 -19.05M。

Relmada Therapeutics Inc 年度营业利润是多少？



Relmada Therapeutics Inc 2025 财年的营业利润为 -59.10M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。